Molecular mechanisms by which selenoproteins affect cancer risk and progression

被引:68
作者
Zhuo, Pin [1 ]
Diamond, Alan M. [1 ]
机构
[1] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2009年 / 1790卷 / 11期
关键词
Selenoprotein; Polymorphism; Cancer; Loss of heterozygosity; Anti-oxidant; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; SINGLE-NUCLEOTIDE POLYMORPHISM; GPX1 PRO198LEU POLYMORPHISM; SELENIUM-CONTAINING PROTEIN; PROSTATE-CANCER; BREAST-CANCER; NO ASSOCIATION; HUMAN-PLASMA; PROMOTER POLYMORPHISMS; 3'-UNTRANSLATED REGION;
D O I
10.1016/j.bbagen.2009.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Selenoproteins comprise a unique class of proteins that contain selenium in the form of selenocysteine. Several selenoproteins have been implicated in the risk or development of cancers in humans by genetic data. These include Selenoprotein P, 3 members of the glutathione peroxidase family of anti-oxidant enzymes and Sep15. At-risk alleles in the germline indicate a likely role in determining susceptibility to cancer, while loss of heterozygosity or chromosomal epigenetic silencing indicate that the reduction in the levels of the corresponding proteins contribute to malignant progression. Lower levels of these proteins are likely to be detrimental due to the resulting cellular stress and perturbations in important regulatory signaling pathways. The genetic data indicating the involvement of these selenoproteins in cancer etiology are discussed, as are the possible mechanisms by which these genes might promote carcinogenesis. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:1546 / 1554
页数:9
相关论文
共 121 条
[51]   Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant [J].
Ichimura, Y ;
Habuchi, T ;
Tsuchiya, N ;
Wang, LH ;
Oyama, C ;
Sato, K ;
Nishiyama, H ;
Ogawa, O ;
Kato, T .
JOURNAL OF UROLOGY, 2004, 172 (02) :728-732
[52]   Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells [J].
Imai, H ;
Nakagawa, Y .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 34 (02) :145-169
[53]   Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression [J].
Irons, R ;
Carlson, BA ;
Hatfield, DL ;
Davis, CD .
JOURNAL OF NUTRITION, 2006, 136 (05) :1311-1317
[54]   Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism [J].
Jablonska, Ewa ;
Gromadzinska, Jolanta ;
Sobala, Wojciech ;
Reszka, Edyta ;
Wasowicz, Wojciech .
EUROPEAN JOURNAL OF NUTRITION, 2008, 47 (01) :47-54
[55]   Selenium and colorectal adenoma:: Results of a pooled analysis [J].
Jacobs, ET ;
Jiang, RY ;
Alberts, DS ;
Greenberg, ER ;
Gunter, EW ;
Karagas, MR ;
Lanza, E ;
Ratnasinghe, L ;
Reid, ME ;
Schatzkin, A ;
Smith-Warner, SA ;
Wallace, K ;
Martínez, ME .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (22) :1669-1675
[56]   Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck [J].
Jefferies, S ;
Kote-Jarai, Z ;
Goldgar, D ;
Houlston, R ;
Frazer-Williams, MJ ;
A'Hern, R ;
Eeles, R .
ORAL ONCOLOGY, 2005, 41 (05) :455-461
[57]   The fundamental role of epigenetic events in cancer [J].
Jones, PA ;
Baylin, SB .
NATURE REVIEWS GENETICS, 2002, 3 (06) :415-428
[58]   Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival [J].
Kim, Hyunki ;
Kang, Hyun Ju ;
You, Kwon Tae ;
Kim, Se Hoon ;
Lee, Kang Young ;
Kim, Tae Il ;
Kim, Chul ;
Song, Si Young ;
Kim, Hye-Jung ;
Lee, Cheolju ;
Kim, Hoguen .
PROTEOMICS, 2006, 6 (11) :3466-3476
[59]   Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the breast cancer family registry [J].
Knight, JA ;
Onay, UV ;
Wells, S ;
Li, H ;
Shi, EJQ ;
Andrulis, IL ;
Ozcelik, H .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (01) :146-149
[60]   Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer [J].
Kote-Jarai, Z ;
Durocher, F ;
Edwards, SM ;
Hamoudi, R ;
Jackson, RA ;
Ardern-Jones, A ;
Murkin, A ;
Dearnaley, DP ;
Kirby, R ;
Houlston, R .
PROSTATE CANCER AND PROSTATIC DISEASES, 2002, 5 (03) :189-192